東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

FindBook

Google Book

Amazon

博客來

Chemical Tools to Interrogate and Inhibit Bacterial Exotoxins.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Chemical Tools to Interrogate and Inhibit Bacterial Exotoxins./
作者:	Garland, Megan Marie.
出版者:	Ann Arbor : ProQuest Dissertations & Theses, : 2021,
面頁冊數:	377 p.
附註:	Source: Dissertations Abstracts International, Volume: 83-03, Section: B.
Contained By:	Dissertations Abstracts International83-03B.
標題:	Infections. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=28654940
ISBN:	9798522954383

Chemical Tools to Interrogate and Inhibit Bacterial Exotoxins.
Garland, Megan Marie.

Chemical Tools to Interrogate and Inhibit Bacterial Exotoxins. - Ann Arbor : ProQuest Dissertations & Theses, 2021 - 377 p.

Source: Dissertations Abstracts International, Volume: 83-03, Section: B.

Thesis (Ph.D.)--Stanford University, 2021.

This item must not be sold to any third party vendors.

Antibiotic resistance is a significant emerging health threat. Exacerbating this problem is the overprescription of antibiotics as well as a lack of development of new antibacterial agents. A paradigm shift towards the development of non-antibiotic agents that target the virulence factors of bacterial pathogens is one way to begin to address the issue of resistance. Of particular interest are compounds targeting bacterial toxins that protect against toxin-induced pathology without harming healthy commensal microbial flora. Development of successful anti-toxin agents would likely decrease the use of antibiotics, thereby reducing selective pressure that leads to resistance mutations. In addition, anti-toxin agents are not only promising for therapeutic applications, but also can be used as tools to study the role of toxins in bacterial pathogenesis. This work highlights strategies to combat two pathogenic bacteria by specifically targeting and neutralizing virulence factors that cause human disease. Toxin B (or TcdB) is elaborated by the bacterium Clostridioides (formerly Clostridium) difficile, an opportunistic bacterial pathogen that is a prevalent cause of nosocomial infections. Botulinum neurotoxins (BoNTs) from Clostridial spp. are the causative agents of botulism, a life-threatening flaccid paralysis caused by toxin internalization with or without an accompanying bacterial infection. Both TcdB and BoNTs are multidomain proteins that contain a protease domain. TcdB contains a cysteine-protease domain important for autoprocessing and BoNT contains a zinc-dependent metalloprotease domain that cleaves host proteins important for the propagation of neuronal action potentials. We hypothesized that cell-permeant, small-molecule inhibitors of the protease domains of these toxins would mitigate bacterial pathology in the host. Using activity-based probes to screen for covalent modifiers of reactive active site and active- site adjacent cysteines of TcdB and BoNT, we identified a preference for selenide-based small-molecule inhibitors for both toxins. We show that the parent selenide, ebselen, inhibits TcdB and BoNT by forming an irreversible covalent selenium-cysteine bond. Biochemical, cell-based, and animal model studies revealed nanomolar protection by ebselen and its analogs against toxin-induced pathology for BoNT and TcdB. Together, these data identify a class of selenide small-molecules that are cell-permeant, non-toxic and active against multiple bacterial toxins that can also be used to study the roles of these toxins in bacterial pathogenesis. Further, these compounds are ideal candidates for potential development as broad-spectrum antivirulence agents.

ISBN: 9798522954383Subjects--Topical Terms:

1621997
Infections.

Chemical Tools to Interrogate and Inhibit Bacterial Exotoxins.
LDR:03719nmm a2200301 4500 001 2352030
005 20221111120957.5
008 241004s2021 ||||||||||||||||| ||eng d
020 $a 9798522954383
035 $a (MiAaPQ)AAI28654940
035 $a (MiAaPQ)STANFORDcn643kw2881
035 $a AAI28654940
040 $a MiAaPQ $c MiAaPQ
100 1 $a Garland, Megan Marie. $3 3691642
245 1 0 $a Chemical Tools to Interrogate and Inhibit Bacterial Exotoxins.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2021
300 $a 377 p.
500 $a Source: Dissertations Abstracts International, Volume: 83-03, Section: B.
500 $a Advisor: Bogyo, Matthew; Grimes, Kevin; Lowe, Anson W.
502 $a Thesis (Ph.D.)--Stanford University, 2021.
506 $a This item must not be sold to any third party vendors.
520 $a Antibiotic resistance is a significant emerging health threat. Exacerbating this problem is the overprescription of antibiotics as well as a lack of development of new antibacterial agents. A paradigm shift towards the development of non-antibiotic agents that target the virulence factors of bacterial pathogens is one way to begin to address the issue of resistance. Of particular interest are compounds targeting bacterial toxins that protect against toxin-induced pathology without harming healthy commensal microbial flora. Development of successful anti-toxin agents would likely decrease the use of antibiotics, thereby reducing selective pressure that leads to resistance mutations. In addition, anti-toxin agents are not only promising for therapeutic applications, but also can be used as tools to study the role of toxins in bacterial pathogenesis. This work highlights strategies to combat two pathogenic bacteria by specifically targeting and neutralizing virulence factors that cause human disease. Toxin B (or TcdB) is elaborated by the bacterium Clostridioides (formerly Clostridium) difficile, an opportunistic bacterial pathogen that is a prevalent cause of nosocomial infections. Botulinum neurotoxins (BoNTs) from Clostridial spp. are the causative agents of botulism, a life-threatening flaccid paralysis caused by toxin internalization with or without an accompanying bacterial infection. Both TcdB and BoNTs are multidomain proteins that contain a protease domain. TcdB contains a cysteine-protease domain important for autoprocessing and BoNT contains a zinc-dependent metalloprotease domain that cleaves host proteins important for the propagation of neuronal action potentials. We hypothesized that cell-permeant, small-molecule inhibitors of the protease domains of these toxins would mitigate bacterial pathology in the host. Using activity-based probes to screen for covalent modifiers of reactive active site and active- site adjacent cysteines of TcdB and BoNT, we identified a preference for selenide-based small-molecule inhibitors for both toxins. We show that the parent selenide, ebselen, inhibits TcdB and BoNT by forming an irreversible covalent selenium-cysteine bond. Biochemical, cell-based, and animal model studies revealed nanomolar protection by ebselen and its analogs against toxin-induced pathology for BoNT and TcdB. Together, these data identify a class of selenide small-molecules that are cell-permeant, non-toxic and active against multiple bacterial toxins that can also be used to study the roles of these toxins in bacterial pathogenesis. Further, these compounds are ideal candidates for potential development as broad-spectrum antivirulence agents.
590 $a School code: 0212.
650 4 $a Infections. $3 1621997
650 4 $a Cancer. $3 634186
650 4 $a Infectious diseases. $3 2179310
650 4 $a Pathogens. $3 3540520
650 4 $a Antibiotics. $3 670318
650 4 $a Bacterial infections. $3 3559961
650 4 $a Bacteria. $3 550366
650 4 $a Biopsy. $3 1360224
650 4 $a Edema. $3 1602730
650 4 $a Cholera. $3 2071496
650 4 $a E coli. $3 3556834
650 4 $a Whooping cough. $3 3691643
650 4 $a Antigens. $3 700737
650 4 $a Peptides. $3 605772
650 4 $a Contrast agents. $3 3681940
650 4 $a Kinases. $3 3558077
650 4 $a Virulence. $3 720303
650 4 $a Drug resistance. $3 1602664
650 4 $a Disease control. $3 3562653
650 4 $a Drug dosages. $3 3557732
650 4 $a Proteins. $3 558769
650 4 $a Pharmaceutical sciences. $3 3173021
690 $a 0572
710 2 $a Stanford University. $3 754827
773 0 $t Dissertations Abstracts International $g 83-03B.
790 $a 0212
791 $a Ph.D.
792 $a 2021
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=28654940